PRKCSH and lung carcinoma: PRKCSH suppression, either by siRNA to suppress PRKCSH expression level or selective glucosidase II inhibitor, induced autophagy in both wild-type p53 and p53-null lung carcinoma cells, while apoptosis was triggered exclusively in cells carrying wild-type p53 (27).